Enflurane
Structural formula | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||
Simplified structural formula without stereochemistry 1: 1 mixture of ( S ) form and ( R ) form |
|||||||||||||||||||
General | |||||||||||||||||||
Non-proprietary name | Enflurane | ||||||||||||||||||
other names |
( RS ) -2-chloro-1-difluoromethoxy-1,1,2-trifluoroethane |
||||||||||||||||||
Molecular formula | C 3 H 2 ClF 5 O | ||||||||||||||||||
Brief description |
colorless liquid with a mild, sweet odor |
||||||||||||||||||
External identifiers / databases | |||||||||||||||||||
|
|||||||||||||||||||
Drug information | |||||||||||||||||||
ATC code | |||||||||||||||||||
Drug class | |||||||||||||||||||
properties | |||||||||||||||||||
Molar mass | 184.49 g · mol -1 | ||||||||||||||||||
Physical state |
liquid |
||||||||||||||||||
density |
1.5167 g cm −3 (25 ° C) |
||||||||||||||||||
boiling point |
56.5 ° C |
||||||||||||||||||
Vapor pressure |
233 h Pa (20 ° C) |
||||||||||||||||||
solubility |
slightly soluble in water (5.62 g l −1 at 25 ° C) |
||||||||||||||||||
Refractive index |
1.3025 (20 ° C) |
||||||||||||||||||
safety instructions | |||||||||||||||||||
|
|||||||||||||||||||
MAK |
150 mg m −3 |
||||||||||||||||||
Toxicological data | |||||||||||||||||||
Global warming potential |
705 (based on 100 years) |
||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . Refractive index: Na-D line , 20 ° C |
Enflurane is a volatile anesthetic from the group of flurans, similar to halothane . It has good hypnotic and muscle relaxing effects , but only weak analgesic effects. It is no longer used worldwide , partly because of its narrow cardiovascular safety margin .
Chemistry and pharmacology
The blood-gas distribution coefficient of enflurane is 1.9, that is, at a concentration of 1 percent by volume ( % by volume ) in the alveoli , the concentration in the blood is 1.9% by volume. This results in a medium-fast sleep and wake-up phase. The minimum alveolar concentration is 1.68%, so enflurane is about as potent as isoflurane . Enflurane is only slightly irritating to the mucous membranes.
The rate of metabolism of enflurane is 2-3%, which means that the likelihood of liver damage is low. The importance of the resulting fluoride compounds has not yet been clarified. Enflurane increases the tendency to cramp, muscle twitching up to myoclonus and epileptiform seizures , especially in connection with hyperventilation , have been described. The antihypertensive effect of enflurane is more pronounced than that of the other inhalation anesthetics. Like the other inhalation anesthetics , enflurane increases intracranial pressure and triggers malignant hyperthermia and porphyria.
Individual evidence
- ↑ a b c d e f g h i Entry on enflurane in the GESTIS substance database of the IFA , accessed on April 11, 2020(JavaScript required) .
- ↑ David R. Lide (Ed.): CRC Handbook of Chemistry and Physics . 90th edition. (Internet version: 2010), CRC Press / Taylor and Francis, Boca Raton, FL, Physical Constants of Organic Compounds, pp. 3-228.
- ↑ G. Myhre, D. Shindell et al .: Climate Change 2013: The Physical Science Basis . Working Group I contribution to the IPCC Fifth Assessment Report. Ed .: Intergovernmental Panel on Climate Change . 2013, Chapter 8: Anthropogenic and Natural Radiative Forcing, pp. 24-39; Table 8.SM.16 ( PDF ).
- ↑ Reinhard Larsen: Anesthesia and intensive medicine in cardiac, thoracic and vascular surgery. (1st edition 1986) 5th edition. Springer, Berlin / Heidelberg / New York et al. 1999, ISBN 3-540-65024-5 , pp. 6-8.